Table 1.
Direct and indirect costs for the treatments of the study population.
| Pneumococcal Meningitis n = 10 | Pneumonia n = 53 | Acute Otitis Media n = 67 | ||
|---|---|---|---|---|
| Direct costs, € | Mean ± SD | 9,299.98 ± 13,762.01 | 1,317.76 ± 3,179.1 | 20.57 ± 7.64 |
| Median (Q1-Q3) | 3,346.38 (941.82–11,700.86) | 480.66 (202.36–891.13) | 17.59 (17.59–17.59) | |
| Service cost | Mean ± SD | 6,889.99 ± 11,532.51 | 879.84 ± 2,255.03 | NA |
| Median (Q1-Q3) | 1,794.41 (648.83–8,914.87) | 296.69 (175.60–574.53) | NA | |
| Medication cost | Mean ± SD | 1,719.31 ± 2,698.07 | 331.92 ± 1,142.81 | NA |
| Median (Q1-Q3) | 485.24 (275.35–2,068.33) | 68.2 (31.33–230.44) | NA | |
| Material cost | Mean ± SD | 690.68 ± 1,170.44 | 106 ± 324.31 | NA |
| Median (Q1-Q3) | 322.84 (24.16–615.96) | 8.08 (1.84–50.88) | NA | |
| Indirect costs, € | Mean ± SD | 2,472.32 ± 3,078.55 | 474.23 ± 448.67 | 106.15 ± 30.45 |
| Median (Q1-Q3) | 829.18 (483.65–3,255.39) | 330.09 (214.91–560.44) | 99.73 (99.73–99.73) | |
| Total Cost, € | Mean ± SD | 11,772.3 ± 16,688.16 | 1,792.00 ± 3,472.51 | 126.72 ± 36.07 |
| Median (Q1-Q3) | 4,060.38 (1,463.87–14,959.24) | 835.91 (405.31–1,458.12) | 117.32 (117.32–117.32) |
SD, standard deviation; Q1, 1st quartile (25th percentile); Q3, 3rd quartile (75th percentile); NA, not available